Xilio Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.05

+0.01 (+0.11%)

As of Sep 28, 10:32 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +451.8% upside

Low Target $27.43

Average Target $49.94

High Target $65.11

Current Price $9.05

Current
$9.05

Target
$49.94

$27.43 $49.94 avg $65.11

Scenario Analysis

Bear Case

$27.43

203.1%

Low target

Base Case

$49.94

+451.8%

Avg target

Bull Case

$65.11

+619.4%

High target

Risk/Reward

3.1x

Highly favorable

Price in Context

52-Week High

$12.74

-29.0% from high

52-Week Low

$6.47

+39.9% from low

Target vs 52W High

$49.94

+292.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%